News & Events

19.02.2021 | NMI Reutlingen

Multiplex antibody tests

The antibody test developed in Reutlingen is sensitive and accurate. This is also confirmed by independent experts who reviewed the validation study prior to its publication.

[read more]

16.02.2021 | NMI Reutlingen

In vitro Veritas

We are pleased to announce the funding of Wellcome Leap under the HOPE program to develop a novel multi-organ chip with partners from academia and industry.

[read more]

12.02.2021 | NMI Reutlingen

Stress and mental illness

The NMI has received funding from the German Research Foundation (DFG) to investigate the impact of stress on health.

[read more]

15.01.2021 | Reutlingen

NMI employee elected Spokesperson of the microTEC Südwest Expert Group on Micro Medical Technologies

Dr.-Ing. René von Metzen, department head at the NMI, was elected spokesperson for the Micro Medical Technologies Expert Group ...

[read more]

27.11.2020 | NMI Reutlingen

Member of the 4D-Bioprinting Network

Since November 2020, the NMI is a partner in the international ZIM network "4D Bioprinting" (FKZ 16KN098801). This network consists of European SMEs and research institutions that are jointly researching innovative bio inks and ...

[read more]

10.11.2020 | digital

Young scientist wins second prize at Young Scientists Lecture

Kathrin Stadelmann, scientist of the Biomedical Micro and Nano Engineering group at the NMI, won the second prize at the Young Scientists Lecture.

[read more]

03.7.2020 | Reutlingen

Representative, nationwide corona antibody study starts in Reutlingen

A nationwide antibody study by the Helmholtz Centre for Infection Research (HZI) was launched in the district of Reutlingen at the beginning of July with the aim of gaining a better overview of the occurrence of SARS-CoV-2 infections.

[read more]

25.6.2020 | Stuttgart

innBW founds association

While the Innovation Alliance Baden-Württemberg, in short innBW, can already look back on a long history, the 13 member institutes joined together to form an association on 24 June.

[read more]

10.6.2020 | global

CORESMA provides evidence-based data about corona measures

The NMI is collaborating in an international project consortium named CORESMA in which clinical, epidemiological and immunological data will be collected and ...

[read more]

© NMI

The Natural and Medical Sciences Institute (NMI) at the University of Tübingen undertakes applied research and development at the interface of life sciences and material sciences. An interdisciplinary team of scientists opens up and develops new technologies for companies and public research sponsors.

The NMI subsidiary offers customers from the pharmaceutical, biotechnology and medical device industries an integrated portfolio of products and services.

On site in Berlin - In 2015 launched a laboratory at the Bayer CoLaborator.

Investigation of smallest structures, insight into the world of atoms

The Center for Nanoanalysis at the NMI is a regional contact point for innovative companies with material technology issues and product ideas.

Business Areas

Schnelleinstieg für den Bereich Pharma und Biotechnologie
Pharma & biotechnology
Schnelleinstieg für den Bereich Biomedizintechnik
Biomedical technology
Schnelleinstieg für den Bereich Oberflauml;chen- und Werkstofftechnologie
Surface & materials technology